Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Applied Health Economics and Health Policy
Erschienen in: Applied Health Economics and Health Policy 6/2018

01.12.2018 | Original Research Article

Estimation of the Direct Cost of Poliomyelitis Rehabilitation Treatment to Pakistani Patients: A 53-Year Retrospective Study

verfasst von: Atta Abbas Naqvi, Syed Baqir Shyum Naqvi, Fatima Zehra, Ashutosh Kumar Verma, Saman Usmani, Sehrish Badar, Rizwan Ahmad, Niyaz Ahmad

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Pakistan is one of the last few countries in which poliomyelitis is endemic. Evidence indicates that out-of-pocket expenditures are a barrier to polio rehabilitation treatment, yet there are no reported figures related to the financial burden of this disease on patients in a recently polio-endemic country.

Objective

This study investigated direct costs attributed to rehabilitation treatment of poliomyelitis among Pakistani patients and reported its duration along with the socioeconomic status of poliomyelitis survivors.

Conclusion

The cost of poliomyelitis rehabilitation in Pakistan is high; it has an economic effect on the lives of patients and their families. Despite good education, polio survivors in Pakistan appear to have low socioeconomic status, lower chances of employment and marriage, as well as fewer children. Further research is recommended to explore the burden of disease on society, i.e., indirect costs and suffering.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Nielsen NM, Kay L, Wanscher B, Ibsen R, Kjellberg J, Jennum P. Long-term socio-economic consequences and health care costs of poliomyelitis: a historical cohort study involving 3606 polio patients. J Neurol. 2016;263:1120–8.CrossRef
2.
Centers for Disease Control and Prevention; Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015.
3.
4.
Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172:1213–29.CrossRef
5.
6.
7.
Shaikh MA, Kamal A, Naqvi I. University Students perspective on polio vaccination: ruse or realistic need for Pakistani children? J Pak Med Assoc. 2014;64:694–6.PubMed
8.
Silver JK, Wilson DJ. Polio voices: an oral history from the American polio epidemics and worldwide eradication efforts. Westport: Greenwood Publishing Group; 2007.
9.
Thompson KM, Duintjer Tebbens RJ. Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Analysis. 2006;26(6):1423–40.CrossRef
10.
Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Linkins J, Sutter RW, et al. Economic analysis of the global polio eradication initiative. Vaccine. 2010;29:334–43.CrossRef
11.
12.
Farbu E, Gilhus NE. Education, occupation, and perception of health amongst previous polio patients compared to their siblings. Eur J Neurol. 2002;9:233–41.CrossRef
13.
Farbu E, Rekand T, Aarli JA, Gilhus NE. Polio survivors—well educated and hard working. J Neurol. 2001;248:500–5.CrossRef
14.
Abbas A, Yazdani N. Polio dilemma: a wake-up call for Pakistan. Med Sci. 2014;13:88–9.
15.
16.
Naqvi AA, Naqvi SB, Zehra F, Ahmad R, Ahmad N. The cost of poliomyelitis: lack of cost-of-illness studies on poliomyelitis rehabilitation in Pakistan. Arch Pharma Pract. 2016;7:182–4.CrossRef
17.
18.
19.
20.
Weiss MT. Physical therapy examination and treatment of the polio survivor. Learning about and from post-poliomyelitis: a seminar for physical and occupational therapists and physical and occupational therapists assitants. Eighth International Post-Polio and Independent Living Conference; 8–10 Jun 2000; Saint Louis.
21.
22.
23.
Gera N. Pakistan’s healthcare under structural adjustment. Lahore J Econ. 2003;8:65–81.
24.
25.
De Vellis RF. Scale development: theory and applications. 26th ed. Thousand Oaks: Sage; 1991.
26.
Cohen JS. Statistical power analysis for the behavioral sciences. 2nd ed. Hillside: Lawrence Erlbaum Associates Inc.; 1988.
27.
Fisher RA. On the interpretation of χ2 from contingency tables, and the calculation of P. J Royal Stat Soc. 1922;85:87–94.CrossRef
28.
Fisher RA. Statistical methods for research workers. Edinburgh: Oliver and Boyd; 1954.
29.
Bang H, Suh JH, Lee SY, Kim K, Yang EJ, Jung SH, et al. Post-polio syndrome and risk factors in korean polio survivors: a baseline survey by telephone interview. Ann Rehabil Med. 2014;38:637–47.CrossRef
30.
Song KM, Choe YJ, Cho H, Bae GR, Lee JK. National action plan for response to poliovirus importation. Osong Public Health Res Perspect. 2011;2:65–71.CrossRef
31.
Groce NE, Banks LM, Stein MA. Surviving polio in a post-polio world. Soc Sci Med. 2014;107:171–8.CrossRef
32.
33.
Naqvi AA, Naqvi SBS, Yazdani N, Ahmad R, Ahmad N, Zehra F. Understanding the dynamics of poliomyelitis spread in Pakistan. Iran J Public Health. 2017;47:997–8.
34.
35.
36.
Naqvi AA, Naqvi SBS, Shahid S, Yazdani N. Barriers to rehabilitation treatment among poliomyelitis infected patients in Karachi, Pakistan: a mix-methods study. Khyber Med Univ J. 2016;8(1):12–21.
37.
Khan MA, Kanwal N. Is unending polio because of religious militancy in Pakistan? A case of Federally Administered Tribal Areas. Int J Dev Conflict. 2015;5:32–47.
38.
39.
Sheikh A, Iqbal B, Ehtamam A, Rahim M, Shaikh HA, Usmani HA, et al. Reasons for non-vaccination in pediatric patients visiting tertiary care centers in a polio-prone country. Arch Public Health. 2013;71:19.CrossRef
40.
41.
Werhagen L, Borg K. Analysis of long-standing nociceptive and neuropathic pain in patients with post-polio syndrome. J Neurol. 2010;257:1027–31.CrossRef
42.
Bertolasi L, Danese A, Monaco S, Turri M, Borg K, Werhagen L. Polio patients in northern Italy, a 50 year follow-up. Open Neurol J. 2016;10:77–82.CrossRef
43.
Naeem H. Understanding Pakistani culture. Bloomington: Author House; 2012.
44.
Sheikh A, Ali S, Ejaz S, Farooqi M, Ahmed SS, Jawaid I. Malpractice awareness among surgeons at a teaching hospital in Pakistan. Patient Saf Surg. 2012;6:26.CrossRef
45.
Yousafzai AW. Corruption in medical practice: where do we stand? J Ayub Med Coll Abbottabad. 2015;27:515–6.PubMed
46.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Oxford: Oxford University; 2006.CrossRef
47.
Zeilig G, Weingarden H, Shemesh Y, Herman A, Heim M, Zeweker M, et al. Functional and environmental factors affecting work status in individuals with longstanding poliomyelitis. J Spinal Cord Med. 2012;35:22–7.CrossRef
48.
Metadaten
Titel
Estimation of the Direct Cost of Poliomyelitis Rehabilitation Treatment to Pakistani Patients: A 53-Year Retrospective Study
verfasst von
Atta Abbas Naqvi
Syed Baqir Shyum Naqvi
Fatima Zehra
Ashutosh Kumar Verma
Saman Usmani
Sehrish Badar
Rizwan Ahmad
Niyaz Ahmad
Publikationsdatum
01.12.2018
Verlag
Springer International Publishing
Erschienen in
Applied Health Economics and Health Policy / Ausgabe 6/2018
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-018-0422-6

Weitere Artikel der Ausgabe 6/2018

Applied Health Economics and Health Policy 6/2018 Zur Ausgabe

Original Research Article

Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model

Systematic Review

Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review

Original Research Article

Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018–2040

Original Research Article

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates

Review Article

Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review

Current Opinion

Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry